Search
Actuate Therapeutics Inc
ACTUAdd to Watchlist
1.110USD
-0.060-5.13%
Close 07-31 16:00（ET）Quotes delayed by 15 min
26.32MMarket Cap
LossP/E TTM
ACTU Financials
See Actuate Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Actuate Therapeutics Inc Earnings Date
Latest Release
May 14, 2026
EPS / Forecast
-0.24/-0.22
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.06
24.31%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its current assets were 13.64M, with a year-on-year change of 48.17.
What are the total assets of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its total assets of Actuate Therapeutics Inc were 14.04M, with a year-on-year change of 50.62.
What are the total liabilities of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its total liabilities of Actuate Therapeutics Inc were 6.11M, with a year-on-year change of -33.67.
What is the total equity of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its total equity of Actuate Therapeutics Inc was 7.92M, with a year-on-year change of 7505.63.
What is the net operating income of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its net operating income of Actuate Therapeutics Inc was -22.50M, with a year-on-year change of 10.59.
What is the net financing of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its net financing of Actuate Therapeutics Inc was 23.72M, with a year-on-year change of -13.81.
What is the Earnings Per Share (EPS) of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.06, with a year-on-year change of 24.31.
What is the net income of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its net income was -22.23M, with a year-on-year change of 18.54.
What is the debt-to-asset ratio of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 2.89, with a year-on-year change of -33.61.
What is the Return on Assets (ROA) of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -190.35, with a year-on-year change of 57.05.
What is the operating profit of Actuate Therapeutics Inc?
According to Actuate Therapeutics Inc's FY2025 earnings report, its operating profit was -22.50M, with a year-on-year change of 10.59.